tetano
Editor, Senior Moderator
J Phys Condens Matter
. 2022 May 3.
doi: 10.1088/1361-648X/ac6c6c. Online ahead of print.
Computational study on the affinity of potential drugs to SARS-CoV-2 main protease
Veronica Martin[SUP] 1 [/SUP], Miguel Sanz-Novo[SUP] 1 [/SUP], Iker Leon[SUP] 1 [/SUP], Pilar Redondo[SUP] 2 [/SUP], Antonio Largo[SUP] 2 [/SUP], Carmen Barrientos[SUP] 1 [/SUP]
Affiliations
Abstract
Herein, we report a computational investigation of the binding affinity of dexamethasone, betamethasone, chloroquine and hydroxychloroquine to SARS-CoV-2 main protease using Molecular and Quantum Mechanics as well as Molecular Docking methodologies. We aim to provide information on the anti-COVID-19 mechanism of the abovementioned potential drugs against SARS-CoV-2 coronavirus. Hence, the 6w63 structure of the SARS-CoV-2 main protease was selected as potential target site for the Docking analysis. The study includes an initial conformational analysis of dexamethasone, betamethasone, chloroquine and hydroxychloroquine. For the most stable conformers, a spectroscopic analysis has been carried out. In addition, global and local reactivity indexes have been calculated to predict the chemical reactivity of these molecules. The Molecular Docking results indicate that dexamethasone and betamethasone have a higher affinity than chloroquine and hydroxychloroquine for their theoretical 6w63 target. Additionally, dexamethasone and betamethasone show a hydrogen bond with the His41 residue of the 6w63 protein, while the interaction between chloroquine and hydroxychloroquine with this amino acid is weak. Thus, we confirm the importance of His41 amino acid as a target to inhibit the SARS-CoV-2 Mpro activity.
Keywords: Betamethasone; Chloroquine; Dexamethasone; Hydroxychloroquine; Molecular Docking; SARS-CoV-2 main protease.
. 2022 May 3.
doi: 10.1088/1361-648X/ac6c6c. Online ahead of print.
Computational study on the affinity of potential drugs to SARS-CoV-2 main protease
Veronica Martin[SUP] 1 [/SUP], Miguel Sanz-Novo[SUP] 1 [/SUP], Iker Leon[SUP] 1 [/SUP], Pilar Redondo[SUP] 2 [/SUP], Antonio Largo[SUP] 2 [/SUP], Carmen Barrientos[SUP] 1 [/SUP]
Affiliations
- PMID: 35504274
- DOI: 10.1088/1361-648X/ac6c6c
Abstract
Herein, we report a computational investigation of the binding affinity of dexamethasone, betamethasone, chloroquine and hydroxychloroquine to SARS-CoV-2 main protease using Molecular and Quantum Mechanics as well as Molecular Docking methodologies. We aim to provide information on the anti-COVID-19 mechanism of the abovementioned potential drugs against SARS-CoV-2 coronavirus. Hence, the 6w63 structure of the SARS-CoV-2 main protease was selected as potential target site for the Docking analysis. The study includes an initial conformational analysis of dexamethasone, betamethasone, chloroquine and hydroxychloroquine. For the most stable conformers, a spectroscopic analysis has been carried out. In addition, global and local reactivity indexes have been calculated to predict the chemical reactivity of these molecules. The Molecular Docking results indicate that dexamethasone and betamethasone have a higher affinity than chloroquine and hydroxychloroquine for their theoretical 6w63 target. Additionally, dexamethasone and betamethasone show a hydrogen bond with the His41 residue of the 6w63 protein, while the interaction between chloroquine and hydroxychloroquine with this amino acid is weak. Thus, we confirm the importance of His41 amino acid as a target to inhibit the SARS-CoV-2 Mpro activity.
Keywords: Betamethasone; Chloroquine; Dexamethasone; Hydroxychloroquine; Molecular Docking; SARS-CoV-2 main protease.